Diospyros canaliculata
Diospyros canaliculata · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Diospyros canaliculata is a remarkable plant species that has garnered significant scientific interest due to its diverse therapeutic potential. Research has highlighted its potent biological activities, including antibacterial, anthelmintic, and anti-HIV properties. Notably, the plant contains the bioactive chemical plumbagin, which plays a crucial role in its pharmacological profile. This compound contributes to the plant's cytotoxic effects, offering promising avenues for studying its impact on cancer cells. Consequently, Diospyros canaliculata stands as a vital subject in the ongoing search for new medicinal treatments.
- Synonyms
- Diospyros Mayumbensis · Diospyros Kimba-Kimba · 4 more
- Common names
- Not available
- Family
- Ebenaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Diospyros canaliculata is a distinctive plant species known by several different names depending on the region. In certain areas, it is commonly referred to as Baimbro. It is also widely recognized by the descriptive common name Flint Bark. These varying identities highlight the diverse ways local communities interact with the species. Understanding these relationships helps botanists and enthusiasts connect the plant to its cultural and ecological contexts.
Sources: Catalogue of Life (COL)
Synonyms
Diospyros canaliculata is a botanical species recognized by several distinct taxonomic synonyms within scientific literature. It has been previously identified under the names Diospyros bequaertii and Diospyros chlamydocarpa. Additionally, researchers have historically referred to this plant as Diospyros kimba-kimba or Diospyros mayumbensis. The species is also linked to the name Maba coriacea in certain classifications. Understanding these various nomenclatural relationships is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Diospyros canaliculata is a fascinating biological specimen that belongs to the vast kingdom Plantae. Within this expansive realm, the plant is classified under the class Equisetopsida. It further falls into the order Ericales, showcasing its unique evolutionary lineage. As a member of the Ebenaceae family, it shares characteristics with several other notable woody species. Ultimately, its specific identity is defined by its placement within the genus Diospyros.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Ebenaceae |
| Genus | Diospyros |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Diospyros canaliculata is a botanical species with a widespread presence across the African continent. Its geographical range extends significantly into South Tropical Africa, including the nation of Angola. The plant is also highly prevalent throughout West Tropical Africa, where it can be found in various ecological niches. Specifically, it thrives in the diverse landscapes of Ghana, Ivory Coast, and Liberia. Furthermore, its distribution continues through Nigeria, marking it as a key component of the regional flora.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Diospyros canaliculata is a self-supporting tree that establishes a significant presence within its ecosystem. This species exhibits a versatile growth form, ranging from smaller specimens to much larger individuals. While some plants may only reach a minimum height of approximately 4.57 meters, others can grow considerably taller. Most mature trees typically stand between 13.5 meters and 18.29 meters in height. This substantial stature allows the species to thrive as a prominent structural component of the forest canopy.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Diospyros canaliculata has been identified as a source of plumbagin, a compound that demonstrates significant cytotoxic activity. During a study of Cameroonian traditional herbal medicines, this plant was highlighted for its potential role in cancer therapy research. Researchers utilized the National Cancer Institute database to establish a library of cytotoxic compounds, eventually selecting plumbagin for more detailed analysis. Investigations into its activity revealed that its effects are largely associated with enzymatic activity and the structural constituents of ribosomes. This work represents a major step forward in linking Sub-Saharan African medicinal plants to advanced pharmacogenomic mechanistic analysis.
Compounds
Diospyros canaliculata contains plumbagin, a natural compound that has been identified for its potential role in cancer therapy. Within the context of Cameroonian traditional medicine, this specific plant was studied alongside others to establish a library of cytotoxic compounds. Researchers utilized the National Cancer Institute database to analyze the activity of plumbagin against 60 different NCI cell lines. The investigation revealed that the biological activity of this compound is largely associated with enzymatic activity and the structural constituents of ribosomes. This study represents a significant milestone in connecting traditional Sub-Saharan African medicinal plants with advanced pharmacogenomic mechanistic analysis.
Conditions
Diospyros canaliculata contains plumbagin, a compound identified for its significant cytotoxic properties against various cancer cell lines. In a pharmacogenomic study of Cameroonian medicinal plants, this species was highlighted as a source of a highly potent natural product. The activity of plumbagin derived from this plant was analyzed across 60 NCI cell lines to understand its therapeutic potential. Research indicates that the mechanisms of this compound are primarily linked to enzymatic activity and the structural constituents of ribosomes. This connection between the plant and its mechanistic cancer-fighting capabilities represents a major advancement in Sub-Saharan African ethnopharmacology.